Back

PsA Beyond the Joint: Clinical Decision Simulator

1. Recognize the obesity-inflammation axis as a treatment-relevant inflammatory and disease modifier in PsA, including its impact on disease activity and treatment response, to inform clinical reasoning and comprehensive interpretation of disease activity, in 80% of case-based assessment scenarios. 2. Apply individualized treatment strategies that systematically incorporate obesity and metabolic factors when evaluating disease activity (including emerging evidence on the co-management of weight-loss therapies) in people with PsA to optimize joint and systemic control whilst managing adverse events, in 75% of clinical decision scenarios. 3. Apply patient-centred communication strategies to initiate and integrate weight management discussions into PsA care, including setting realistic expectations for concurrent joint and metabolic improvements and supporting shared decision-making, in 70% of simulated clinical interactions. 4. Integrate weight management into PsA care pathways by identifying appropriate patients and facilitating timely treatment, referral or shared care with obesity specialists including building confidence in co-managing modern systemic anti-obesity therapies to support coordinated, multidisciplinary management and improve outcomes, in 70% of pathway-based clinical scenarios.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Aug 31, 2026
  • Last day to claim credit
    Jun 15, 2027 8 months left